B. M. Vose

2.2k total citations
53 papers, 1.7k citations indexed

About

B. M. Vose is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, B. M. Vose has authored 53 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Immunology, 20 papers in Oncology and 7 papers in Molecular Biology. Recurrent topics in B. M. Vose's work include Immunotherapy and Immune Responses (21 papers), Immune Cell Function and Interaction (20 papers) and Cancer Immunotherapy and Biomarkers (10 papers). B. M. Vose is often cited by papers focused on Immunotherapy and Immune Responses (21 papers), Immune Cell Function and Interaction (20 papers) and Cancer Immunotherapy and Biomarkers (10 papers). B. M. Vose collaborates with scholars based in United Kingdom, United States and Sweden. B. M. Vose's co-authors include Michael G. Moore, Farkas Vánky, Michael Moore, Guy D. Bonnard, R W Baldwin, E. Klein, D Glaves, Eva Klein, G D Bonnard and R B Herberman and has published in prestigious journals such as Nature, The Journal of Immunology and JNCI Journal of the National Cancer Institute.

In The Last Decade

B. M. Vose

53 papers receiving 1.5k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
B. M. Vose 1.2k 642 306 262 92 53 1.7k
Theodora W. Salcedo 931 0.7× 495 0.8× 403 1.3× 237 0.9× 104 1.1× 30 1.5k
V von Fliedner 1.2k 0.9× 881 1.4× 411 1.3× 381 1.5× 90 1.0× 54 2.1k
Hervé Brailly 824 0.7× 582 0.9× 299 1.0× 202 0.8× 62 0.7× 33 1.4k
Ilana Yron 789 0.6× 432 0.7× 335 1.1× 144 0.5× 86 0.9× 42 1.3k
Emiel Van Roost 855 0.7× 383 0.6× 234 0.8× 101 0.4× 87 0.9× 14 1.3k
Frederick R. Aronson 692 0.6× 596 0.9× 234 0.8× 84 0.3× 73 0.8× 28 1.2k
Naoko Nakano 1.3k 1.0× 525 0.8× 408 1.3× 121 0.5× 188 2.0× 26 1.9k
Timothy R. Hercus 1.1k 0.9× 458 0.7× 454 1.5× 183 0.7× 93 1.0× 39 1.8k
M B Widmer 699 0.6× 313 0.5× 295 1.0× 183 0.7× 91 1.0× 18 1.2k
Lap-Ping Chung 585 0.5× 297 0.5× 423 1.4× 156 0.6× 96 1.0× 27 1.4k

Countries citing papers authored by B. M. Vose

Since Specialization
Citations

This map shows the geographic impact of B. M. Vose's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. M. Vose with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. M. Vose more than expected).

Fields of papers citing papers by B. M. Vose

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. M. Vose. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. M. Vose. The network helps show where B. M. Vose may publish in the future.

Co-authorship network of co-authors of B. M. Vose

This figure shows the co-authorship network connecting the top 25 collaborators of B. M. Vose. A scholar is included among the top collaborators of B. M. Vose based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. M. Vose. B. M. Vose is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Akaza, Hideyuki, Yasuo Ohashi, Tadashi Ikeda, et al.. (2002). [Post launch studies].. PubMed. 29(11). 2037–48. 2 indexed citations
2.
Akaza, Hideyuki, Kazuhiro Aiba, Seiji Isonishi, et al.. (2000). [Development of molecular targeting drugs for the treatment of cancer-therapeutic potential and issues to be addressed in global development].. PubMed. 27(11). 1681–93. 3 indexed citations
3.
Caestecker, Mark P. de, et al.. (1993). Detection of abnormal peripheral blood mononuclear cell cytokine networks in human IgA nephropathy. Kidney International. 44(6). 1298–1308. 42 indexed citations
4.
Campbell, David G. & B. M. Vose. (1985). T-cell control of IgA production. I. Distribution, activation conditions and culture of isotype-specific regulatory helper cells.. PubMed. 56(1). 81–91. 13 indexed citations
5.
Vose, B. M.. (1984). Activation of lymphocyte anti-tumor responses in man. Towards an understanding of effector cell heterogeneity?. Cancer Immunology Immunotherapy. 17(2). 73–75. 6 indexed citations
6.
7.
8.
Vose, B. M., et al.. (1983). Tumour-reactive lymphocytes stimulated in mixed lymphocyte and tumour culture. Cancer Immunology Immunotherapy. 15(3). 227–36. 57 indexed citations
9.
Vose, B. M., G. Blackledge, Derek Crowther, & John T. Gallagher. (1982). Lectin-binding characteristics of human natural killer cells.. PubMed. 46(3). 619–27. 12 indexed citations
10.
Vose, B. M., Philip M. Gallagher, Michael G. Moore, & P F Schofield. (1981). Specific and non-specific lymphocyte cytotoxicity in colon carcinoma. British Journal of Cancer. 44(6). 846–855. 56 indexed citations
11.
Vose, B. M.. (1981). Expansion of autorecognitive cytotoxic effectors in human cancer by T cell growth factor (Interleukin 2)1.. PubMed. 51(4). 317–26. 6 indexed citations
12.
Vose, B. M.. (1980). Tumor Associated Antigens and Their Specific Immune Response. British Journal of Cancer. 41(4). 672–672. 28 indexed citations
13.
Klein, E., Farkas Vánky, Uri Galili, B. M. Vose, & M. Fopp. (1980). Separation and Characteristics of Tumor-Infiltrating Lymphocytes in Man. PubMed. 10. 79–107. 39 indexed citations
14.
Vose, B. M.. (1979). Functional Activity of Human Tumor-Infiltrating Macrophages. Advances in experimental medicine and biology. 114. 783–787. 4 indexed citations
15.
Vose, B. M., Farkas Vánky, & E. Klein. (1977). Human tumour—lymphocyte interaction in vitro. V. Comparison of the reactivity of tumour‐infiltrating, blood and lymph‐node lymphocytes with autologous tumour cells. International Journal of Cancer. 20(6). 895–902. 103 indexed citations
16.
Vose, B. M. & Michael Moore. (1975). Cell mediated immunoreactivity in human lung neoplasia. British Journal of Cancer. 31(2). 261–261. 18 indexed citations
17.
Vose, B. M., et al.. (1975). Cell‐mediated cytotoxicity to human pulmonary neoplasms. International Journal of Cancer. 15(2). 308–320. 17 indexed citations
18.
Baldwin, R W & B. M. Vose. (1974). Embryonic Antigen Expression on 2-Acetylaminofluorene Induced and Spontaneously Arising Rat Tumours. British Journal of Cancer. 30(3). 209–214. 7 indexed citations
19.
Baldwin, R W, M. J. Embleton, Michael R. Price, & B. M. Vose. (1974). Embryonic Antigen Expression on Experimental Rat Tumours. Immunological Reviews. 20(1). 77–99. 40 indexed citations
20.
Baldwin, Robert W. & B. M. Vose. (1974). THE EXPRESSION OF A PHASE-SPECIFIC FOETAL ANTIGEN ON RAT EMBRYO CELLS. Transplantation. 18(6). 525–530. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Theodora W. Salcedo Breakdown of academic impact, for papers by V von Fliedner Breakdown of academic impact, for papers by Hervé Brailly Breakdown of academic impact, for papers by Ilana Yron Breakdown of academic impact, for papers by Emiel Van Roost Breakdown of academic impact, for papers by Frederick R. Aronson Breakdown of academic impact, for papers by Naoko Nakano Breakdown of academic impact, for papers by Timothy R. Hercus Breakdown of academic impact, for papers by M B Widmer Breakdown of academic impact, for papers by Lap-Ping Chung
Rankless by CCL
2026